These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9587601)
1. Activity of pentamidine-loaded poly (D,L-lactide) nanoparticles against Leishmania infantum in a murine model. Durand R; Paul M; Rivollet D; Fessi H; Houin R; Astier A; Deniau M Parasite; 1997 Dec; 4(4):331-6. PubMed ID: 9587601 [TBL] [Abstract][Full Text] [Related]
2. Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model. Durand R; Paul M; Rivollet D; Houin R; Astier A; Deniau M Int J Parasitol; 1997 Nov; 27(11):1361-7. PubMed ID: 9421724 [TBL] [Abstract][Full Text] [Related]
3. Ultrastructural changes in parasites induced by nanoparticle-bound pentamidine in a Leishmania major/mouse model. Fusai T; Boulard Y; Durand R; Paul M; Bories C; Rivollet D; Astier A; Houin R; Deniau M Parasite; 1997 Jun; 4(2):133-9. PubMed ID: 9296058 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic evaluation of free and nanocapsule-encapsulated atovaquone in the treatment of murine visceral leishmaniasis. Cauchetier E; Paul M; Rivollet D; Fessi H; Astier A; Deniau M Ann Trop Med Parasitol; 2003 Apr; 97(3):259-68. PubMed ID: 12803857 [TBL] [Abstract][Full Text] [Related]
5. Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model. Fusai T; Deniau M; Durand R; Bories C; Paul M; Rivollet D; Astier A; Houin R Parasite; 1994 Dec; 1(4):319-24. PubMed ID: 9140499 [TBL] [Abstract][Full Text] [Related]
6. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis. Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis. Cauchetier E; Paul M; Rivollet D; Fessi H; Astier A; Deniau M Int J Parasitol; 2000 May; 30(6):777-83. PubMed ID: 10856513 [TBL] [Abstract][Full Text] [Related]
9. Leishmania infantum amastigote nucleoside triphosphate diphosphohydrolase 1 (NTPDase 1): Its inhibition as a new insight into mode of action of pentamidine. Maia ACRG; Porcino GN; Detoni ML; Quellis LR; Emídio NB; Marconato DG; Messias WF; Soldati LL; Faria-Pinto P; Capriles PVDSZ; Coimbra ES; Marques MJ; Vasconcelos EG Exp Parasitol; 2019 May; 200():1-6. PubMed ID: 30904692 [TBL] [Abstract][Full Text] [Related]
10. Histamine H1-receptor antagonists against Leishmania (L.) infantum: an in vitro and in vivo evaluation using phosphatidylserine-liposomes. Pinto EG; da Costa-Silva TA; Tempone AG Acta Trop; 2014 Sep; 137():206-10. PubMed ID: 24905294 [TBL] [Abstract][Full Text] [Related]
11. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum. Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum. Buffet PA; Garin YJ; Sulahian A; Nassar N; Derouin F Ann Trop Med Parasitol; 1996 Jun; 90(3):295-302. PubMed ID: 8758143 [TBL] [Abstract][Full Text] [Related]
13. In vivo antileishmanial action of Ir-(COD)-pentamidine tetraphenylborate on Leishmania donovani and Leishmania major mouse models. Loiseau PM; Mbongo N; Bories C; Boulard Y; Craciunescu DG Parasite; 2000 Jun; 7(2):103-8. PubMed ID: 10887656 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis. Valadares DG; Duarte MC; Ramírez L; Chávez-Fumagalli MA; Martins VT; Costa LE; Lage PS; Ribeiro TG; Castilho RO; Fernandes AP; Régis WC; Soto M; Tavares CA; Coelho EA Exp Parasitol; 2012 Oct; 132(2):228-36. PubMed ID: 22824583 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum. Rosypal AC; Hall JE; Bakunova S; Patrick DA; Bakunov S; Stephens CE; Kumar A; Boykin DW; Tidwell RR Vet Parasitol; 2007 Apr; 145(3-4):207-16. PubMed ID: 17298866 [TBL] [Abstract][Full Text] [Related]
16. The activity and ultrastructural localization of primaquine-loaded poly (d,l-lactide) nanoparticles in Leishmania donovani infected mice. Rodrigues JM; Croft SL; Fessi H; Bories C; Devissaguet JP Trop Med Parasitol; 1994 Sep; 45(3):223-8. PubMed ID: 7899792 [TBL] [Abstract][Full Text] [Related]
17. Activity of (-)alpha-bisabolol against Leishmania infantum promastigotes. Morales-Yuste M; Morillas-Márquez F; Martín-Sánchez J; Valero-López A; Navarro-Moll MC Phytomedicine; 2010 Mar; 17(3-4):279-81. PubMed ID: 19577452 [TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of bisnaphthalimidopropyl derivatives loaded into pegylated nanoparticles against Leishmania infantum protozoa. Costa Lima S; Rodrigues V; Garrido J; Borges F; Kong Thoo Lin P; Cordeiro da Silva A Int J Antimicrob Agents; 2012 May; 39(5):424-30. PubMed ID: 22398197 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi. Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]